Trials / Completed
CompletedNCT02158065
Impact of "Telecoaching Program" on Physical Activity in Patients With COPD
A 3-month Multicenter Randomized Trial to Evaluate the Efficacy of a Physical Activity Promotion Program on the Experience of Physical Activity in Patients With COPD (Mr PAPP)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 370 (actual)
- Sponsor
- KU Leuven · Academic / Other
- Sex
- All
- Age
- 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this 3 month randomized intervention study is to investigate the additional effect of a physical activity telecoaching program on physical activity in patients with COPD, compared with usual care.
Detailed description
In this 3 month, randomized (1:1 ratio), parallel-group, multicenter trial, patients in both groups (control and coaching) will receive information and guidance on the benefits associated with increased physical activity in COPD patients and their health status. Patients in both groups will use two PROactive monitors (ActiGraph® and DynaPort®) and a PDA to complete the PROactive questionnaire. In addition to above, the patients in the coaching group will receive daily coaching by a semiautomated system and coaching by the investigator during study visits.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Coaching program | The coaching program consists of a (1) Step counter used as a coaching activity monitor to collect number of steps walked by the patients and (2) the Linkcare System, a mobile phone or tablet PC placed in the patient's home to collect data from the step counter. The system will set a daily activity goal for the patient based on achieved activity levels which will be measured by the step counter. Patients will also receive feedback, motivational and educational messages and direct calls from the coaching team at each institution. |
Timeline
- Start date
- 2014-05-01
- Primary completion
- 2015-03-01
- Completion
- 2015-03-01
- First posted
- 2014-06-06
- Last updated
- 2015-05-01
Locations
6 sites across 5 countries: Belgium, Greece, Netherlands, Switzerland, United Kingdom
Source: ClinicalTrials.gov record NCT02158065. Inclusion in this directory is not an endorsement.